School of Medicine


Showing 1-50 of 530 Results

  • Oscar J. Abilez

    Oscar J. Abilez

    Instructor, Medicine - Cardiovascular Medicine

    Current Research and Scholarly Interests Bioengineering, biophysical control of cardiovascular development, pluripotent stem cell biology, optogenetics, electrophysiology, cell mechanics, directed cellular evolution, multiscale engineering, microfluidics, computational biology

  • Steven R. Alexander, MD

    Steven R. Alexander, MD

    Professor of Pediatrics (Nephrology) at the Lucile Salter Packard Children's Hospital

    Current Research and Scholarly Interests Dialysis, kidney transplantation, continuous renal replacement therapy in pediatric patients; chronic kidney disease in pediatric patients.

  • Ash A. Alizadeh, MD/PhD

    Ash A. Alizadeh, MD/PhD

    Associate Professor of Medicine (Oncology)

    Current Research and Scholarly Interests My research is focused on attaining a better understanding of the initiation, maintenance, and progression of tumors, and their response to current therapies toward improving future treatment strategies. In this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.

    Clinically, I specialize in the care of patients with lymphomas, working on translating our findings in prospective cancer clinical trials.

  • Russ B. Altman

    Russ B. Altman

    Kenneth Fong Professor and Professor of Bioengineering, of Genetics, of Medicine (General Medical Discipline), of Biomedical Data Science and, by courtesy, of Computer Science

    Current Research and Scholarly Interests I refer you to my web page for detailed list of interests, projects and publications. In addition to pressing the link here, you can search "Russ Altman" on http://www.google.com/

  • Cristina M. Alvira

    Cristina M. Alvira

    Assistant Professor of Pediatrics (Critical Care)

    Current Research and Scholarly Interests The overall objective of the Alvira Laboratory is to elucidate the mechanisms that promote postnatal lung development and repair, by focusing on three main scientific goals: (i) identification of the signaling pathways that direct the transition between the saccular and alveolar stages of lung development; (ii) exploration of the interplay between postnatal vascular and alveolar development; and (iii) determination of developmentally regulated pathways that mediate lung repair after injury.

  • Manuel R. Amieva

    Manuel R. Amieva

    Associate Professor of Pediatrics (Infectious Diseases) and of Microbiology and Immunology

    Current Research and Scholarly Interests My laboratory studies the strategies pathogens utilize to colonize and subvert the epithelial barrier. We have focused on the epithelial junctions as a target for bacterial pathogens, since the cell-cell junctions serve as both a barrier to infection and also a major control site for epithelial function. In particular, we are interested in how the gastric pathogen Helicobater pylori may cause cancer by interfering with cell signaling at the epithelial junctions. We are also studying how various bacteria cross and invade the epithelium. For example, we recently found that Listeria monocytogenes targets a specialized subset of cell-cell junctions at the tip of the intestinal villi to find its receptor for invasion. We are interested in determining whether this mode of gastrointestinal invasion of the epithelium is also used by other gastrointestinal pathogens.

  • Kanwaljeet Anand

    Kanwaljeet Anand

    Professor of Pediatrics (Pediatric Critical Care) and of Anesthesiology, Perioperative and Pain Medicine at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. Anand is a translational clinical researcher who pioneered research on the endocrine-metabolic stress responses of infants undergoing surgery and developed the first-ever scientific rationale for pain perception in early life. This provided a framework for newer methods of pain assessment, numerous clinical trials of analgesia/anesthesia in newborns, infants and older children. His research focus over the past 30+ years has contributed fundamental knowledge about pediatric pain/stress, long-term effects of pain in early life, management of pain, mechanisms for opioid tolerance and withdrawal. Current projects in his laboratory are focused on developing biomarkers for repetitive pain/stress in critically ill children and the mechanisms underlying sedative/anesthetic neurotoxicity in the immature brain. He designed and directed many randomized clinical trials (RCT), including the largest-ever pediatric analgesia trial studying morphine therapy in ventilated preterm neonates. He has extensive experience in clinical and translational research from participating in collaborative networks funded by NIMH, NINDS, or NICHD, a track-record of excellent collaboration across multiple disciplines, while achieving success with large research teams like the Collaborative Pediatric Critical Care Research Network (CPCCRN). He played a leadership roles in CANDLE (Condition Affecting Neuro-Development & Learning in Early infancy) and other activities of the Urban Child Institute and UT Neuroscience Institute. More recently, he led the NeoOpioid Consortium funded by the European Commission, which collected data from 243 NICUs in 18 European countries.

  • Jason Andrews

    Jason Andrews

    Assistant Professor of Medicine (Infectious Diseases) and, by courtesy, of Health Research and Policy (Epidemiology)

    Current Research and Scholarly Interests Our laboratory aims to develop and test innovative approaches to the diagnosis, treatment and control of infectious diseases in resource-limited settings. We draw upon multiple fields including mathematical modeling, microbial genetics, field epidemiology, statistical inference and biodesign to work on challenging problems in infectious diseases, with an emphasis on tuberculosis and tropical diseases.

  • Justin P. Annes M.D., Ph.D.

    Justin P. Annes M.D., Ph.D.

    Assistant Professor of Medicine (Endocrinology)

    Current Research and Scholarly Interests The ANNES LABORATORY of Molecular Endocrinology: Leveraging Chemical Biology to Treat Endocrine Disorders

    DIABETES
    The prevalence of diabetes is increasing at a staggering rate. By the year 2050 an astounding 25% of Americans will be diabetic. The goal of my research is to uncover therapeutic strategies to stymie the ensuing diabetes epidemic. To achieve this goal we have developed a variety of innovate experimental approaches to uncover novel approaches to curing diabetes.

    (1) Beta-Cell Regeneration: Diabetes results from either an absolute or relative deficiency in insulin production. Our therapeutic strategy is to stimulate the regeneration of insulin-producing beta-cells to enhance an individual?s insulin secretion capacity. We have developed a unique high-throughput chemical screening platform which we use to identify small molecules that promote beta-cell growth. This work has led to the identification of key molecular pathways (therapeutic targets) and candidate drugs that promote the growth and regeneration of islet beta-cells. Our goal is to utilize these discoveries to treat and prevent diabetes.

    (2) The Metabolic Syndrome: A major cause of the diabetes epidemic is the rise in obesity which leads to a cluster of diabetes- and cardiovascular disease-related metabolic abnormalities that shorten life expectancy. These physiologic aberrations are collectively termed the Metabolic Syndrome (MS). My laboratory has developed an original in vivo screening platform t to identify novel hormones that influence the behaviors (excess caloric consumption, deficient exercise and disrupted sleep-wake cycles) and the metabolic abnormalities caused by obesity. We aim to manipulate these hormone levels to prevent the development and detrimental consequences of the MS.

    HEREDIATY PARAGAGLIOMA SYNDROME
    The Hereditary Paraganglioma Syndrome (hPGL) is a rare genetic cancer syndrome that is most commonly caused by a defect in mitochondrial metabolism. Our goal is to understand how altered cellular metabolism leads to the development of cancer. Although hPGL is uncommon, it serves as an excellent model for the abnormal metabolic behavior displayed by nearly all cancers. Our goal is to develop novel therapeutic strategies that target the abnormal behavior of cancer cells. In the laboratory we have developed hPGL mouse models and use high throughput chemical screening to identify the therapeutic susceptibilities that result from the abnormal metabolic behavior of cancer cells.

    As a physician scientist trained in clinical genetics I have developed expertise in hereditary endocrine disorders and devoted my efforts to treating families affected by the hPGL syndrome. By leveraging our laboratory expertise in the hPGL syndrome, our care for individuals who have inherited the hPGL syndrome is at the forefront of medicine. Our goal is to translate our laboratory discoveries to the treatment of affected families.

  • David Ansel

    David Ansel

    Clinical Assistant Professor, Pediatrics

    Bio I am a Developmental-Behavioral Pediatrician (DBP) with clinical interests that include developmental delay, intellectual and learning disabilities, ADHD, autism, Asperger?s, anxiety, obsessive-compulsive, tic disorders, and psychopharmacology.

    The first 28 years of my career were spent in clinical practice combining both DBP and primary care (the latter focused on serving CSHCN). During those years I was involved in numerous divide-bridging efforts - including programs to coordinate inpatient & outpatient medicine, connect tertiary & primary care, and promote teamwork between pediatricians, psychologists, nurse practitioners, and other community partners. I founded my own solo practice in 1989 and managed its growth to an 8-provider group over the next 25 years. Our practice was a founding member of the PPOC and I served on its board of directors for 6 years. The PPOC is one of the largest pediatric IPA?s in the country, with >200 member providers affiliated with Boston Children's Hospital. Over the years we've been involved in groundbreaking QI initiatives including those involving asthma, weight, and ADHD management; medical home; and behavioral health integration with primary care.

    I?m pleased now to have an opportunity for a ?second act? on the clinician-educator track here at Stanford. I hope to use my unique experience straddling primary care and sub-specialty worlds to develop programs supporting DB assessment and care inside the medical home generally, and across the Packard Children's Health Alliance primary care network in particular.

  • Eric A. Appel

    Eric A. Appel

    Assistant Professor of Material Science and Engineering and, by courtesy, of Bioengineering

    Current Research and Scholarly Interests The underlying theme of the Appel Lab at Stanford University integrates concepts and approaches from supramolecular chemistry, natural/synthetic materials, and biology. We aim to develop supramolecular biomaterials that exploit a diverse design toolbox and take advantage of the beautiful synergism between physical properties, aesthetics, and low energy consumption typical of natural systems. Our vision is to use these materials to solve fundamental biological questions and to engineer advanced healthcare solutions.

  • Ronald L. Ariagno

    Ronald L. Ariagno

    Professor (Clinical) of Pediatrics, Emeritus

    Current Research and Scholarly Interests Developmental Physiology and Sudden Infant Death Syndrome Research Laboratory closed in 2008.

    Current effort, as Chair of Task Force and neonatal consult at the FDA, is to establish through consensus a culture of investigation and collaboration for all clinical neonatology practices: academic, corporate and community based to maximize the opportunity to participate in research effort needed for the regulatory approval of neonatal therapeutics to improve the outcome of critically ill infants.

  • Steven Artandi

    Steven Artandi

    Jerome and Daisy Low Gilbert Professor and Professor of Biochemistry

    Current Research and Scholarly Interests Telomeres are nucleoprotein complexes that protect chromosome ends and shorten with cell division and aging. We are interested in how telomere shortening influences cancer, stem cell function, aging and human disease. Telomerase is a reverse transcriptase that synthesizes telomere repeats and is expressed in stem cells and in cancer. We have found that telomerase also regulates stem cells and we are pursuing the function of telomerase through diverse genetic and biochemical approaches.

  • Ann M. Arvin

    Ann M. Arvin

    Lucile Salter Packard Professor of Pediatrics and Professor of Microbiology and Immunology

    Current Research and Scholarly Interests Our laboratory investigates the pathogenesis of varicella zoster virus (VZV) infection, focusing on the functional roles of particular viral gene products in pathogenesis and virus-cell interactions in differentiated human cells in humans and in Scid-hu mouse models of VZV cell tropisms in vivo, and the immunobiology of VZV infections.

  • Euan A. Ashley

    Euan A. Ashley

    Professor of Medicine (Cardiovascular) and, by courtesy, of Pathology at the Stanford University Medical Center

    Current Research and Scholarly Interests The Ashley lab is focused on precision medicine. We develop methods for the interpretation of whole genome sequencing data to improve diagnosis of genetic disease and to personalize the practice of medicine. We also use network approaches to characterize biology. The wet bench is where we take advantage of cell systems, transgenic models and microsurgical models of disease to prove causality of our favorite targets.

  • Tim L. Assimes, MD PhD

    Tim L. Assimes, MD PhD

    Associate Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Health Research and Policy (Epidemiology)

    Current Research and Scholarly Interests Genetic Epidemiology, Genetic Determinants of Complex Traits related to Cardiovasular Medicine, Coronary Artery Disease related pathway analyses and integrative genomics, Mendelian randomization studies, risk prediction for major adverse cardiovascular events, cardiovascular medicine related pharmacogenomics, ethnic differences in the determinants of Insulin Mediated Glucose Uptake, pharmacoepidemiology of cardiovascular drugs & outcomes

  • Laura Attardi

    Laura Attardi

    Professor of Radiation Oncology (Radiation and Cancer Biology) and of Genetics

    Current Research and Scholarly Interests Our research is aimed at defining the pathways of p53-mediated apoptosis and tumor suppression, using a combination of biochemical, cell biological, and mouse genetic approaches. Our strategy is to start by generating hypotheses about p53 mechanisms of action using primary mouse embryo fibroblasts (MEFs), and then to test them using gene targeting technology in the mouse.

  • Jeffrey Axelrod

    Jeffrey Axelrod

    Professor of Pathology

    Current Research and Scholarly Interests Genetic and cell biological analyses of signals controlling cell polarity and morphogenesis. Frizzled signaling and cytoskeletal organization.

  • Rosa Bacchetta

    Rosa Bacchetta

    Associate Professor (Research) of Pediatrics (Stem Cell Transplantation)

    Current Research and Scholarly Interests In the coming years, I plan to further determine the genetic and immunological basis of diseases with autoimmunity or immune dysregulation in children. I believe that much can still be learned from the in depth mechanistic studies of pediatric autoimmune diseases. Genomic analysis of the patients' samples has become possible which may provide a rapid indication of altered target molecules. I plan to implement robust functional studies to define the consequences of these genetic abnormalities and bridge them to the patient's clinical phenotype.

    Understanding functional consequences of gene mutations in single case/family first and then validating the molecular and cellular defects in other patients with similar phenotypes, will anticipate and complement cellular and gene therapy strategies.

    For further information please visit the Bacchetta Lab website:
    http://med.stanford.edu/bacchettalab.html

  • Laura K. Bachrach

    Laura K. Bachrach

    Professor of Pediatrics (Endocrinology) at the Lucile Salter Packard Children's Hospital

    Current Research and Scholarly Interests Prevention of osteoporosis begins in childhood and adolescence by measures that maximize acquistion of bone mineral during the critical adolescent years. Body mass, calcium nutriture, physical activity, growth and sex steroid hormones, and genetic factors are all thought to be important determinants of bone mass although the relative contribution of each remains controversial.

  • Julie Baker

    Julie Baker

    Professor of Genetics

    Current Research and Scholarly Interests Our laboratory is focused on identifying proteins based upon their ability to alter a variety of cell fate decisions - including mesodermal, endodermal, neural, endothelial, and somitic - within the vertebrate embryo.

  • Valerie L. Baker, MD

    Valerie L. Baker, MD

    Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility) at the Stanford University Medical Center

    Current Research and Scholarly Interests primary ovarian insufficiency, premature ovarian failure, infertilty, assisted reproductive technology, ovulation induction, hormone therapy

  • Maria Barna

    Maria Barna

    Assistant Professor of Genetics and of Developmental Biology

    Current Research and Scholarly Interests Our lab studies how intricate control of gene expression and cell signaling is regulated on a minute-by-minute basis to give rise to the remarkable diversity of cell types and tissue morphology that form the living blueprints of developing organisms. Work in the Barna lab is presently split into two main research efforts. The first is investigating ribosome-mediated control of gene expression genome-wide in space and time during cellular differentiation and organismal development. This research is opening a new field of study in which we apply sophisticated mass spectrometry, computational biology, genomics, and developmental genetics, to characterize a ribosome code to gene expression. Our research has shown that not all of the millions of ribosomes within a cell are the same and that ribosome heterogeneity can diversify how genomes are translated into proteomes. In particular, we seek to address whether fundamental aspects of gene regulation are controlled by ribosomes harboring a unique activity or composition that are tuned to translating specific transcripts by virtue of RNA regulatory elements embedded within their 5?UTRs. The second research effort is centered on employing state-of-the-art live cell imaging to visualize cell signaling and cellular control of organogenesis. This research has led to the realization of a novel means of cell-cell communication dependent on a dense network of actin-based cellular extension within developing organs that interconnect and facilitate the precise transmission of molecular information between cells. We apply and create bioengineering tools to manipulate such cellular interactions and signaling in-vivo.

  • Patrick D. Barnes MD

    Patrick D. Barnes MD

    Professor of Radiology (Pediatric Radiology) at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly Interests Advanced imaging, including magnetic resonance imaging, of injury to the developing central nervous system; including fetal, neonatal, infant and young child; and, including nonaccidental injury (e.g. child abuse).

  • Richard Barth

    Richard Barth

    Professor of Radiology (Pediatric Radiology) at the Stanford University Medical Center

    Current Research and Scholarly Interests Magnetic Resonance Imaging and Sonographic diagnosis of fetal anomalies.
    Focus interest in the diagnosis and conservative (non-surgical and minimal radiation) management of congenital broncho pulmonary malformations.
    Imaging of appendicitis in children.
    Sonography of the pediatric testis.

  • Dorsey Bass

    Dorsey Bass

    Associate Professor of Pediatrics (Gastroenterology) at the Lucile Salter Packard Children's Hospital

    Current Research and Scholarly Interests Our laboratory is interested in the pathophysiology, immunology, and epidemiology of viral gastroenteritis.

  • Sanjay Basu

    Sanjay Basu

    Assistant Professor of Medicine (Primary Care and Outcomes Research) and, by courtesy, of Health Research and Policy (Epidemiology)

    Current Research and Scholarly Interests mathematical models
    operations research
    primary care
    public health
    econometrics
    global health
    social determinants of health
    health policy
    health disparities

  • Fiona Baumer

    Fiona Baumer

    Instructor, Neurology & Neurological Sciences

    Current Research and Scholarly Interests I am researching the neurobiology underlying cognitive problems in pediatric epilepsy. I am using transcranial magnetic stimulation paired with EMG and EEG to study cortical excitability and plasticity in children with benign epilepsy with centrotemporal spikes (BECTS or Rolandic Epilepsy). I am investigating whether changes in plasticity affect a child's ability to learn.

  • Barry R. Behr, PhD, HCLD

    Barry R. Behr, PhD, HCLD

    Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility) at the Stanford University Medical Center

    Current Research and Scholarly Interests Development of improved embryo culture conditions in vitro. Blastocyst cultures. Embryo metabolism in vitro. Embryo maternal dialogue. Clinical application and integration of extended embryo culture systems. Monozygotic twinning. Prevention of multiple pregnancy. Sperm motility enhancers. Fluorescent and non-fluorescent markers of sperm morphology and viablility. Oocyte cryopreservation. Fertility preservation. Improving IVF outcome.

  • Gill Bejerano

    Gill Bejerano

    Associate Professor of Developmental Biology, of Computer Science, of Biomedical Data Science and of Pediatrics (Genetics)

    Current Research and Scholarly Interests Dr. Bejerano, co-discoverer of ultraconserved elements, studies the Human Genome. His research focuses on genome sequence and function in both humans and related primate, mammalian and vertebrate species. He is deeply interested in mapping both coding and non-coding genome sequence variation to phenotype differences, and in extracting specific genetic insights from high throughput sequencing measurements, in the contexts of development and developmental abnormalities.

  • Eran Bendavid

    Eran Bendavid

    Associate Professor of Medicine (Primary Care and Population Health) and, by courtesy, of Health Research and Policy

    Current Research and Scholarly Interests Effect of global health policies on health of individuals in developing countries, global health, HIV and TB.

  • William Benitz

    William Benitz

    Philip Sunshine, M.D., Professor in Neonatology and Professor, by courtesy, of Obstetrics and Gynecology at the Stanford University Medical Center

    Current Research and Scholarly Interests Neonatology, patent ductus arteriosus, pulmonary hypertension of the newborn, infant ventilation, neonatal clinical protocols/clinical pathways.

  • David Bergman

    David Bergman

    Associate Professor of Pediatrics (General Pediatrics) at the Lucile Salter Packard Children's Hospital, Emeritus

    Current Research and Scholarly Interests My research has involved the use of new technologies to create different types of patient-doctor transactions. I am also interested in how these new transactions impact clinical care processes. Current work includes the evaluation of a patient portal for children with cystic fibrosis, the use of telemedicine to bring asthma experts into the schools and the attitudes of teens and parents about the use of a secure patient portal for teens.

  • Michele Berk

    Michele Berk

    Assistant Professor of Psychiatry and Behavior Sciences (Child and Adolescent Psychiatry and Child Development) at the Stanford University Medical Center

    Current Research and Scholarly Interests The focus of my research is on adolescent suicidal and self-harm behavior. I am currently one of four Principal Investigators of a multisite NIMH-sponsored RCT of DBT for adolescents at high risk for suicide (NCT01528020: Collaborative Adolescent Research on Emotions and Suicide [CARES], PI: Linehan, McCauley, Berk, & Asarnow) aimed at evaluating the efficacy of DBT with adolescents compared to a combined individual and group supportive therapy control condition (IGST).

  • Daniel Bernstein

    Daniel Bernstein

    Alfred Woodley Salter and Mabel Smith Salter Endowed Professor in Pediatrics

    Current Research and Scholarly Interests 1. Role of the G protein coupled receptors in regulating mitochondrial structure and function.
    2. Differences between R and L ventricular responses to stress, including gene expression and miR regulation.
    3. Using iPSC-derived myocytes to understand heart failure and congenital heart disease.
    4. Tools for evaluation of cardiac physiology in transgenic mice and isolated cardiomyocytes.
    5. Anti-body mediated rejection.
    6. Biomarkers for post-transplant lymphoproliferative disorder.

  • Jon Bernstein

    Jon Bernstein

    Associate Professor of Pediatrics (Genetics) at the Lucile Salter Packard Children's Hospital and, by courtesy, of Genetics

    Current Research and Scholarly Interests My interests include the genetics of autism and other developmental disorders. In collaboration with colleagues at Stanford, I am working to develop induced pluripotent stem cell (iPSC) models of genetic disorders associated with developmental disability. I am also engaged in the application of new technologies (Whole genome sequencing, Multi-omics profiling) for the diagnosis of developmental disorders.

  • Edward Bertaccini

    Edward Bertaccini

    Professor of Anesthesiology, Perioperative and Pain Medicine at the Palo Alto Veterans Affairs Health Care System

    Current Research and Scholarly Interests molecular modeling of anesthetic-protein interactions, molecular modeling of the ligand-gated ion channels

  • Alice Bertaina

    Alice Bertaina

    Associate Professor of Pediatrics (Stem Cell Transplantation) at the Lucile Salter Packard Children's Hospital

    Current Research and Scholarly Interests Dr. Bertaina is a highly experienced clinician and will play a key role in supporting Section Chief Dr. Rajni Agarwal and Clinical Staff in the Stem Cell Transplant Unit at Lucile Packard Children?s Hospital. She will also continue her research on immune recovery and miRNA, understanding the mechanisms underlying immune reconstitution, Graft-versus-Host Disease (GvHD), and leukemia relapse after allogeneic HSCT in pediatric patients affected by hematological malignant and non-malignant disorders.

  • Carolyn Bertozzi

    Carolyn Bertozzi

    Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences and Professor, by courtesy, of Radiology and of Chemical and Systems Biology

    Bio Professor Carolyn Bertozzi's research interests span the disciplines of chemistry and biology with an emphasis on studies of cell surface sugars important to human health and disease. Her research group profiles changes in cell surface glycosylation associated with cancer, inflammation and bacterial infection, and uses this information to develop new diagnostic and therapeutic approaches, most recently in the area of immuno-oncology.

    Dr. Bertozzi completed her undergraduate degree in Chemistry at Harvard University and her Ph.D. at UC Berkeley, focusing on the chemical synthesis of oligosaccharide analogs. During postdoctoral work at UC San Francisco, she studied the activity of endothelial oligosaccharides in promoting cell adhesion at sites of inflammation. She joined the UC Berkeley faculty in 1996. A Howard Hughes Medical Institute Investigator since 2000, she came to Stanford University in June 2015, among the first faculty to join the interdisciplinary institute ChEM-H (Chemistry, Engineering & Medicine for Human Health). Named a MacArthur Fellow in 1999, Dr. Bertozzi has received many awards for her dedication to chemistry, and to training a new generation of scientists fluent in both chemistry and biology. She has been elected to the Institute of Medicine, National Academy of Sciences, and American Academy of Arts and Sciences; and received the Lemelson-MIT Prize, the Heinrich Wieland Prize, and the ACS Award in Pure Chemistry, among many others. Her efforts in undergraduate education have earned the UC Berkeley Distinguished Teaching Award and the Donald Sterling Noyce Prize for Excellence in Undergraduate Teaching.

    Today, the Bertozzi Group at Stanford studies the glycobiology underlying diseases such as cancer, inflammatory disorders such as arthritis, and infectious diseases such as tuberculosis. The work has advanced understanding of cell surface oligosaccharides involved in cell recognition and inter-cellular communication.

    Dr. Bertozzi's lab also develops new methods to perform controlled chemical reactions within living systems. The group has developed new tools for studying glycans in living systems, and more recently nanotechnologies for probing biological systems. Such "bioorthoganol" chemistries enable manipulation of biomolecules in their living environment.

    Several of the technologies developed in the Bertozzi lab have been adapted for commercial use. Actively engaged with several biotechnology start-ups, Dr. Bertozzi founded Redwood Bioscience of Emeryville, California, and has served on the research advisory board of GlaxoSmithKline.

  • Vivek Bhalla, MD, FASN, FAHA

    Vivek Bhalla, MD, FASN, FAHA

    Assistant Professor of Medicine (Nephrology) at the Stanford University Medical Center

    Current Research and Scholarly Interests Dr. Bhalla's two primary research interests are in the interaction of the kidney in diabetes and hypertension. We use molecular, biochemical, and transgenic approaches to study mechanisms of physiologic and aberrant ion handling and its consequences for hypertension in obesity and insulin resistance. We also study mechanisms of susceptibility to diabetic kidney disease including the role of the endothelium to regulate inflammation and kidney injury.

Footer Links:

Stanford Medicine Resources: